Exhibit 10.06

 

Confidentia

 

Execution Version

 

IN ACCORDANCE WITH ITEM 601(b)(10)(iv) OF REGULATION S-K, CERTAIN CONFIDENTIAL
INFORMATION HAS BEEN EXCLUDED FROM THIS DOCUMENT BECAUSE IT IS BOTH (I) NOT
MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. THE
CONFIDENTIAL INFORMATION IS DENOTED HEREIN BY [*].

Amyris, Inc.
5885 Hollis Street
Emeryville, CA 94608

 

April 16, 2019

DSM Nutritional Products AG (“DSM”)

DSM Nutritional Products Europe Ltd (the “Assuming Party”)
Wurmisweg 576, CH–4303
Kaiseraugst, Switzerland

Re: Assignment of Value Sharing Agreement

Reference is made to (i) that certain Value Sharing Agreement, by and among
Amyris, Inc. (“Amyris”) and DSM, dated December 28, 2017, as amended by that
certain Amendment No. 1, dated March 31, 2018, Amendment No. 2, dated June 29,
2018, Amendment No. 3, dated June 29, 2018 and Amendment No. 4, dated November
19, 2018 (as amended, the “Value Sharing Agreement”) and (ii) that certain
Supply Agreement dated as of December 28, 2017, by and between Amyris and DSM,
as amended by that certain Amendment No. 1 to the Supply Agreement, dated
November 19, 2018, and Amendment No. 2 to the Supply Agreement, dated as of the
date hereof (as amended, the “Supply Agreement”).

WHEREAS, Amyris desires to assign all of its rights and delegate all of its
obligations under the Value Sharing Agreement to the Assuming Party in exchange
for the consideration provided herein.

NOW, THEREFORE, in consideration of the foregoing, the covenants, agreements and
conditions contained herein, and other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged by DSM, the Assuming
Party and Amyris, and intending to be legally bound hereby, DSM, the Assuming
Party and Amyris, on behalf of themselves and their respective successors and
assigns, hereby agree as follows:

1.                   In consideration for the assignment of the Value Sharing
Agreement by Amyris to the Assuming Party pursuant to the Assignment and
Assumption Agreement attached hereto as Exhibit A, DSM agrees to pay Amyris
total consideration of US$ 57,000,000, which shall be payable as follows:

a.US$7,400,000 (the “Prepayment Amount”) was prepaid by DSM to Amyris on March
29, 2019;

b.DSM shall pay to Amyris an amount equal to US$21,699,143 in cash (the “Cash
Payment”) on or before April 16, 2019 in accordance with wire instructions
provided by Amyris to DSM prior to the date hereof; and

c.US$27,900,857 (the “Amyris Credit Amount”) shall be offset by DSM and the
Assuming Party against existing obligations of Amyris as follows:

 

 

 

Confidential

 

i.US$1,635,520 (thereof US$62,500 interest due) of the Amyris Credit Amount
shall be used to satisfy in full all amounts owing by Amyris to the Assuming
Party in respect of [*] shipments by the Assuming Party to Amyris prior to the
date hereof;

ii.US$7,748,000 of the Amyris Credit Amount shall be used to satisfy in full
Amyris’ obligation to pay US$7,250,000 plus interest to DSM (US$498,000), which
was due prior to March 29, 2019 pursuant to Section 2(ii) of Amendment No. 1 to
the Supply Agreement; and

iii.US$3,797,619 of the Amyris Credit Amount shall be used to satisfy in full
Amyris’ obligation to pay the Additional Payment (as such term is defined in the
Supply Agreement) to DSM, which was due prior to March 29, 2019 pursuant to
Section 2(ii) of Amendment No. 1 to the Supply Agreement.

iv.US$6,893,000 of the Amyris Credit Amount shall be used to satisfy in full
Amyris’ obligation to pay the portion of the Reservation Fee (as such term is
defined in the Supply Agreement) due to DSM prior to July 1, 2019 pursuant to
Section 1(a) of Amendment No. 1 to the Supply Agreement when such amount becomes
payable;

v.US$625,000 of the Amyris Credit Amount shall be used to satisfy in full
Amyris’ obligation to pay the interest currently due and payable under the
outstanding US$25,000,000 Note payable from Amyris to DSM Finance BV, dated
December 28, 2017;

vi.US$902,895 of the Amyris Credit Amount shall be used to satisfy in full
Amyris’ obligation to compensate DSM for the tax loss incurred due to the wrong
invoicing in Brazil;

vii.US$290,330 of the Amyris Credit Amount shall be used to satisfy in full
Amyris’ obligation to compensate DSM for the interests due to the late payment
in Brazil; and

viii.Brazilian Reais 23,054,588 of the Amyris credit amount shall be used to
satisfy in full all amounts owing by Amyris to DSM PRODUTOS NUTRICIONAIS BRASIL
S.A.,Rodovia Brotas / Torrinhas, S/N Km 7,5 Sala A,Fazenda Paraíso - Brotas/SP
with company number CEP: 17380-000 (“DNP Brazil”) in respect of [*] shipments by
DNP Brazil to Amyris prior to the date hereof.

2.Amyris shall use the Cash Payment as follows:

a.a portion of the Cash Payment equal to US$6,893,000 shall be used by Amyris to
satisfy Amyris’ obligation to pay the portion of the Reservation

[*] Certain portions denoted with an asterisk have been omitted.

 

 

Confidential

Fee due to DSM prior to December 15, 2019 pursuant to Section 1(a) of Amendment
No. 1 to the Supply Agreement when such amount becomes payable; and

b.The remainder of the Cash Payment, together with the Prepayment Amount, shall
be used by Amyris without restriction.

Amyris shall have no obligation to segregate or hold separate the portion of the
Cash Payment referenced in Sections 2a and 2b.

3.                   Value Share Prepayments.

The [*] value share credit from the prepayment done in 2018 for 2019 will be
repaid by Amyris to DSM to the extent the cumulative amount of value share
payments Amyris would have been entitled to receive by the end of 2021 had the
Value Sharing Agreement not been assigned hereunder falls short of [*] (e.g. if
the value share payments DSM would have been required to pay Amyris under the
Value Sharing Agreement (and before any off-set via the value share prepayment
credit) is [*] by end of 2021, Amyris will pay DSM then [*]).

4.                   This Agreement may be executed in any number of
counterparts, all of which taken together shall constitute one and the same
instrument and any of the parties hereto may execute this Agreement by signing
any such counterpart. Delivery of an executed counterpart of this Agreement by
email or other electronic method of transmission shall be equally as effective
as delivery of an original executed counterpart. This Agreement shall be
construed in accordance with, and governed by, the laws of the State of New
York, without regard to the conflicts of law provisions thereof. Any dispute
arising out of this Agreement shall be submitted exclusively to any state or
federal court located in New York County, New York, without restricting any
rights of appeal.

[Signature page follows.]

 

 

 

 

[*] Certain portions denoted with an asterisk have been omitted.

 

 

Confidential

Please confirm your agreement and acknowledgement of the matters set forth in
this Agreement by signing in the space provided below.

Sincerely,

Amyris, Inc.

 

_/s/ John Melo_________________

By: John Melo

Title: Chief Executive Officer

Accepted and agreed as of the date first written above:

DSM Nutritional Products AG

 

By: __/s/ Benedikt Suter _______________

Name: Benedikt Suter

Title: General Counsel

By: __/s/ Bruno Mueller________________

Name: Bruno Mueller

Title: Vice-President

DSM Nutritional Products Europe Ltd

 

 

By: __/s/ Benedikt Suter _______________

Name: Benedikt Suter

Title: General Counsel

 

By: _/s/ Peter Fisher__________________

Name: Peter Fisher

Title:

 

 

 

Confidential

 

Exhibit A

ASSIGNMENT AND ASSUMPTION AGREEMENT

This ASSIGNMENT AND ASSUMPTION AGREEMENT, dated as of April 16, 2019 (this
“Agreement”), is entered into by and between Amyris, Inc., a Delaware
corporation (“Assigning Party”), and DSM Nutritional Products Europe Ltd, a
Swiss corporation (“Assuming Party”).

WHEREAS, Assigning Party desires to assign to Assuming Party all of its rights
and delegate to Assuming Party all of its obligation under that certain Value
Sharing Agreement, dated December 28, 2017, by and between Assigning Party and
DSM Nutritional Products AG, as amended by that certain Amendment No. 1, dated
March 31, 2018, Amendment No. 2, dated June 29, 2018, Amendment No. 3, dated
June 29, 2018 and Amendment No. 4, dated November 19, 2018 (as amended, the
“Assigned Agreement”); and

WHEREAS, Assuming Party desires to accept such assignment of rights and
delegation of obligations under the Assigned Agreement;

NOW, THEREFORE, in consideration of the foregoing, and agreements contained
herein, and intending to be legally bound hereby, Assigning Party and Assuming
Party hereby agree as follows:

1.Assignment. Effective as of the Assignment Effective Date (as defined below),
Assigning Party irrevocably sells, assigns, grants, conveys, and transfers to
Assuming Party all of Assigning Party’s right, title and interest in and to, and
all of Assigning Party’s or its affiliates claims related to, the Assigned
Agreement.

2.Assumption. Effective as of the Assignment Effective Date, Assuming Party
unconditionally accepts such assignment and assumes all of Assigning Party’s
duties, liabilities and obligations under the Assigned Agreement, and agrees to
pay, perform and discharge, as and when due, all of the obligations of Assigned
Party under the Assigned Agreement, whether accruing on, prior to or after the
date hereof.

3.Effectiveness. This Agreement shall become effective upon the receipt of the
Cash Payment by the Assigning Party or any of its affiliates from DSM
Nutritional Products AG in accordance with the Assignment of Value Sharing
Agreement letter agreement, dated April 16, 2019 (the “Assignment Effective
Date”).

[Remainder of Page Intentionally Left Blank.]

 

 

 

 

 

Confidential

IN WITNESS WHEREOF, Assigning Party and Assuming Party have caused this
Agreement to be duly executed and delivered by their proper and duly authorized
officers as of the date and year first written above.

 

ASSIGNING PARTY:

 

AMYRIS, INC.

 

 

 

By: /s/ John Melo
Name: John Melo
Title: President and Chief Executive Officer

 

 

ASSUMING PARTY:

 

DSM Nutritional Products Europe Ltd

 

 

 

By: __/s/ Benedikt Suter _______________

Name: Benedikt Suter

Title: General Counsel

 

 

By: _/s/ Peter Fisher__________________

Name: Peter Fisher

Title: